2-Amino-3,4-difluorobenzoic acid is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring both amino and difluoro substituents, makes it valuable for developing compounds with specific biological activities. It is often employed in the production of drugs targeting central nervous system disorders, inflammation, and infections. Additionally, it serves as a building block in organic synthesis, particularly in the creation of complex molecules for medicinal chemistry research. Its fluorine atoms enhance the stability and bioavailability of the resulting compounds, making it a crucial component in drug discovery and development processes.